Status:
UNKNOWN
Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and Ondansetron
Lead Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Collaborating Sponsors:
Chongqing University Jiangjin Hospital
Chongqing Medical University
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
To compare the anti-nausea and vomiting effect between glycopyrronium and ondansetron for patients receiving elective surgery under general anesthesia. Based on this study the investigators intend to ...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists classification I-III
- Receive general anesthesia
- Voluntarily receive postoperative intravenous controlled analgesia
Exclusion
- Puerpera or lactation women
- Allergy or existing contraindication to glycopyrronium and ondansetron
- Participate in other clinical drug trials within three months
- Can not follow with the study procedure
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2023
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT05265507
Start Date
March 21 2022
End Date
May 30 2023
Last Update
February 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital, Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400010